These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 347106)

  • 61. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
    J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer.
    Yokomizo A; Kanimoto Y; Okamura T; Ozono S; Koga H; Iwamura M; Tanaka H; Takahashi S; Tsushima T; Kanayama HO; Akaza H; Shinohara N; Mugiya S; Nomata K; Nakamura T; Naito S
    J Urol; 2016 Jan; 195(1):41-6. PubMed ID: 26307162
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Retrospective study of various conservative treatment options with bacille Calmette-Guérin in bladder urothelial carcinoma T1G3: Maintenance therapy.
    Palou-Redorta J; Solsona E; Angulo J; Fernández JM; Madero R; Unda M; Martínez-Piñeiro JA; Portillo J; Chantada V; Moyano JL
    Actas Urol Esp; 2016; 40(6):370-7. PubMed ID: 26922518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Keyhole-limpet hemocyanin immunotherapy in the bilharzial bladder: a new treatment modality? Phase II trial: superficial bladder cancer.
    Wishahi MM; Ismail IM; Ruebben H; Otto T
    J Urol; 1995 Mar; 153(3 Pt 2):926-8. PubMed ID: 7853576
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognosis of primarily treated localized laryngeal carcinoma ameliorated through levamisole treatment: a randomized pilot study.
    Mussche RA; Kluyskens P
    Oncology; 1980; 37(5):329-35. PubMed ID: 7003457
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of levamisole treatment in cancer patients.
    Amery WK; Verhaegen H
    J Rheumatol Suppl; 1978; 4():123-35. PubMed ID: 366137
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bacillus Calmette-Guerin immunotherapy of infiltrating bladder cancer.
    Netto NR; Lemos GC
    J Urol; 1984 Oct; 132(4):675-7. PubMed ID: 6471211
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The prognostic value of cell surface antigens in low grade, non-invasive, transitional cell carcinoma of the bladder.
    Young AK; Hammond E; Middleton AW
    J Urol; 1979 Oct; 122(4):462-4. PubMed ID: 480485
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Levamisole treatment in ulcus cruris. A double-blind placebo-controlled study.
    Morias J; Peremans W; Campaert H; Mertens RL
    Arzneimittelforschung; 1979; 29(7):1050-2. PubMed ID: 387047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Maintenance therapy for superficial bladder cancer.
    Baselli EC; Greenberg RE
    Oncology (Williston Park); 2001 Jan; 15(1):85-8; discussion 88-91. PubMed ID: 11271984
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intracavitary bacillus Calmette-Guérin for Superficial Bladder Tumors.
    Droller MJ
    J Urol; 2017 Feb; 197(2S):S146-S147. PubMed ID: 28010983
    [No Abstract]   [Full Text] [Related]  

  • 72. Evaluation of cellular immunity following bacillus Calmette-Guérin therapy in patients with superficial bladder cancer.
    Sarica K; Baltaci S; Bedük Y; Süzer O; Kiliç S; Müftüğlu YZ; Göğüş O
    Urol Int; 1995; 54(3):137-41. PubMed ID: 7604454
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Balancing effectiveness and toxicity of levamisole in the treatment of rheumatoid arthritis.
    Runge LA; Rynes RI
    Clin Exp Rheumatol; 1983; 1(2):125-31. PubMed ID: 6398156
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Relapsing Reiter's syndrome after Bacillus Calmette-Guérin immunotherapy for bladder carcinoma].
    Pego JM; Lamas C; Hernández I; Suso J
    Med Clin (Barc); 2003 Sep; 121(9):356-7. PubMed ID: 14499076
    [No Abstract]   [Full Text] [Related]  

  • 75. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Levamisole in advanced human breast cancer.
    Rojas AF; Feierstein JN; Mickiewicz E; Glait H; Olivari AJ
    Lancet; 1976 Jan; 1(7953):211-5. PubMed ID: 55529
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sequential immunocytological evaluation of murine transitional cell carcinoma during intralesional bacillus Calmette-Guerin and interleukin-2 immunotherapy.
    Sosnowski JT; De Haven JI; Abraham FM; Riggs DR; Lamm DL
    J Urol; 1992 May; 147(5):1439-43. PubMed ID: 1569700
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of bacillus Calmette-Guérin in the treatment of superficial bladder cancer: the impact of previous intravesical treatment.
    Okamura T; Akita H; Imura M; Kaneko T; Mizuno K; Tozawa K; Kohri K
    Int J Urol; 2008 Oct; 15(11):976-80. PubMed ID: 18721199
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intravesical Bacillus Calmette-Guerin for treating bladder cancer.
    Boyd LA
    Urol Nurs; 2003 Jun; 23(3):189-91, 199; quiz 192. PubMed ID: 12861735
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial.
    Goossens ME; Zeegers MP; van Poppel H; Joniau S; Ackaert K; Ameye F; Billiet I; Braeckman J; Breugelmans A; Darras J; Dilen K; Goeman L; Tombal B; Van Bruwaene S; Van Cleyenbreugel B; Van der Aa F; Vekemans K; Buntinx F
    Eur J Cancer; 2016 Dec; 69():9-18. PubMed ID: 27814472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.